Strata Skin Sciences announces initiative to expand treatment coverage

STRATA Skin Sciences announced an initiative aimed at expanding insurance coverage for essential treatments for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous T-Cell lymphoma, with an initial targeted focus on expanding coverage for vitiligo and atopic dermatitis, skin diseases effecting up to 3 and 16 million people in the United States respectively. “Our focus extends beyond merely seeking expanded insurance coverage; we’re advocating for the enhancement of patient quality of life and ensuring access to essential dermatologic treatments,” stated Dr. Dolev Rafaeli, Vice Chairman and Chief Executive Officer of STRATA. “By encouraging our patients to voice their needs and by proactively collaborating with policymakers, we’re dedicated to guaranteeing that each person can access the medically necessary care they require.” Dr. Rafaeli continued, “We are encouraged by our initial outreach effort to a segment of our patient database and are using those results to engage with our elected officials to help these individuals and others similarly situated.”